We concluded our participation at ASRM 2026, the American Society for Reproductive Medicine Scientific Congress & Expo, held in Baltimore from October 24 to 28, with two awards recognizing our research on uterine tumor diagnosis.
Throughout the meeting, we also shared research on endometrial assessment, preeclampsia, and artificial intelligence in reproductive medicine, and took part in recognizing Teresa K. Woodruff’s scientific contributions.
Two awards for our uterine tumor research
Our Principal Investigator, Dr. Aymara Mas, presented the oral communication Plasma Cell-Free RNA Machine Learning Classifier Enables Non-Invasive Preoperative Diagnosis of Uterine Leiomyosarcoma (O-8).
The study received the 2026 Fibroid Special Interest Group Prize Paper Award and was also recognized with the Second Place Prize Paper award at the ASRM Scientific Congress.
This research addresses an important challenge in gynecological care: distinguishing benign uterine fibroids from uterine leiomyosarcoma, a rare malignant tumor, before surgery.
To address this challenge, we are investigating the combination of plasma cell-free RNA analysis and machine learning to develop tools that could improve preoperative assessment. Although the findings are promising, further validation is needed before clinical implementation.
These two awards recognize the scientific and clinical relevance of our work toward improving uterine tumor diagnosis. Learn more about the study in our article on MYOSARC.
Endometrial research, preeclampsia, and artificial intelligence
Prof. Carlos Simon, President of our Foundation, contributed to two scientific sessions on October 26.
During ALMER: Tools for the Management of Implantation Failure, he presented Evaluation of the Endometrium, discussing the role of endometrial assessment in the management of implantation failure.
Later that day, he participated in Reproductive Science and Medicine in the Era of Agentic AI, presenting Orchestrating Agentic AI in Reproductive Medicine and discussing potential applications of agentic AI in reproductive medicine.
We also presented the poster Maternal Decidual Dysfunction Impairs Trophoblast Differentiation in Severe Preeclampsia (P-54), exploring how alterations in maternal decidualization may affect trophoblast differentiation, a process essential for placental development. This work is part of our research on maternal factors involved in the origin of preeclampsia.
Teresa K. Woodruff receives the Carlos Simon Excellence in Translational Research Award
On October 27, we participated in the Carlos Simon Translational Research Lunch Symposium, where Teresa K. Woodruff, Ph.D., was recognized with the 2026 Carlos Simon Excellence in Translational Research Award.
Supported by our Foundation, this ASRM award recognizes scientific contributions that have helped translate biomedical research into clinical practice in reproductive medicine.
Dr. Woodruff has played a central role in establishing the field of oncofertility, connecting cancer care with fertility preservation. Her research has also made important contributions to our understanding of ovarian biology and egg development.
With this recognition and the scientific work presented throughout the meeting, we concluded our participation at ASRM 2026, where we had the opportunity to share our findings with reproductive medicine specialists from around the world.